Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$131,060,338
+$2,319,652 QoQ
Shares Held
4,639,304
0.0% QoQ
Ownership
6.64%
of shares outstanding
% of Portfolio
46.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026venBio Partners LLC holds $280,553,199 across 6 Biotechnology names. PHVS ranks #1 (46.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
This page
|
4,639,304 | $131,060,338 | |
| 2 | ALMS |
Alumis Inc.
|
4,528,408 | $99,760,828 | |
| 3 | ALXO |
Alx Oncology Holdings Inc
|
12,884,638 | $25,833,699 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
489,194 | $13,702,323 | |
| 5 | LYEL |
Lyell Immunopharma, Inc.
|
337,697 | $6,774,201 | |
| 6 | ARTV |
Artiva Biotherapeutics, Inc.
|
531,337 | $3,421,810 |
All Filings in PHVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $131,060,338 | 4,639,304 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $128,740,686 | 4,639,304 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $115,750,634 | 4,639,304 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,491,750 | 4,289,304 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,342,072 | 4,289,304 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $82,225,957 | 4,289,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,437,910 | 4,289,304 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $80,638,915 | 4,289,304 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $99,125,815 | 4,289,304 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $137,992,087 | 4,919,504 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $89,003,704 | 4,264,672 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $64,567,134 | 4,264,672 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,353,921 | 2,278,575 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,837,987 | 2,296,710 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,615,765 | 2,296,710 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $50,862,067 | 2,301,451 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $41,770,526 | 2,303,310 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,144,630 | 2,303,310 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $40,837,686 | 2,303,310 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,910,665 | 2,303,310 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $64,446,613 | 2,303,310 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||